Morgan Stanley analyst Meta Marshall maintained a Hold rating on Lumentum Holdings (LITE – Research Report) today and set a price target of $81.00. The company’s shares closed yesterday at $83.98.
The market expects Lumentum (LITE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Lumentum has received approval for near (2030) and long-term (2050) science-based emissions reduction targets from the SBTi. The SBTi has verified Lumentum’s net-zero science-based target by ...
The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors. Lawmakers ...
I liked reading the always-excellent Rob Greenspoon’s post about five (almost) instant fixes to the patent system. The next U.S. Patent and Trademark Office (USPTO) Director would do well to ...
After hours: January 31 at 7:35:22 p.m. EST ...
After hours: 7:35:22 pm GMT-5 ...